<p><em>Expert Perspectives </em>delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. <em>Expert Perspectives in </em><em>Acute Myeloid Leukemia (AML)</em> will feature community-selected experts and topics that we hope you will find of value in your clinical practice.</p> <p> </p> <p>To set the stage for our dedicated coverage of Acute Myeloid Leukemia, the following articles highlight the current challenges, opportunities, and new frontiers in Acute Myeloid Leukemia.</p> <p> </p> <p> </p>

---

VIEW THE TOPICS

 

• Approach to Patients With AML Who Are Ineligible for Intensive Chemotherapy
  Courtney D. DiNardo, MD, MSCE

 

• Combination Strategies to Overcome Hypomethylating Agent Resistance
  Courtney D. DiNardo, MD, MSCE

 

• Maintenance Therapy Post Allogeneic Stem Cell Transplantation in AML
  Andrew M. Brunner, MD

 

• Relapsed AML: Past, Present, and Future
  Courtney D. DiNardo, MD, MSCE

 

• Updates on TP53-Mutant AML
  Andrew M. Brunner, MD